Why the study?
Do inhibitors of the renin-angiotensin system reduce new-onset diabetes in patients with insulin resistance?
Population
Patients with insulin resistance such as primary hypertension, and experimental models of insulin resistance
Design
Review
Authors
Loading...
Supports potential diabetes prevention with RAS inhibitors in insulin resistance; leaves open need for randomized confirmation.
Do inhibitors of the renin-angiotensin system reduce new-onset diabetes in patients with insulin resistance?
Inhibitors of the renin-angiotensin system are associated with a significant reduction in new-onset diabetes in patients with insulin resistance, supported by cross-talk between angiotensin and insulin signaling pathways.
Sharma Prabhakar (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: